Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 47.4% on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The stock has a market capitalization of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm’s 50 day moving average is C$0.07 and its two-hundred day moving average is C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- The Risks of Owning Bonds
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Industrial Products Stocks Investing
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
